Want to join the conversation?
Omar Saad of Evercore ISI asks for an update on HyperAdapt. CEO Mark Parker said the HyperAdapt or the adaptive performance technology is not just centered on fit, but $NKE has got some of the other opportunities from a complete performance standpoint. He added that what will come out in 2Q17 will be the tip of an iceberg that is quite compelling.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?